{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:33:15Z","timestamp":1785540795534,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00210-024-03117-4","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:20:53Z","timestamp":1716582053000},"page":"8069-8075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The use of new antibacterial drugs against infections caused by multidrug-resistant Gram-negative bacteria: an Italian real-world evidence study in a Lombardy hospital"],"prefix":"10.1007","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6783","authenticated-orcid":false,"given":"Francesco","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pasquinucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bagaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-6057","authenticated-orcid":false,"given":"Maurizio","family":"Capuozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-2171","authenticated-orcid":false,"given":"Andrea","family":"Zovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"3117_CR1","unstructured":"Annual Epidemiological Reports (AERs) (2024) https:\/\/www.ecdc.europa.eu\/en\/publications-data\/monitoring\/all-annual-epidemiological-reports. Accesed January 2024"},{"issue":"3","key":"3117_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/molecules27030616","volume":"27","author":"A Catalano","year":"2022","unstructured":"Catalano A, Iacopetta D, Ceramella J et al (2022) Multidrug resistance (MDR): a widespread phenomenon in pharmacological therapies. Molecules 27(3):616. https:\/\/doi.org\/10.3390\/molecules27030616","journal-title":"Molecules"},{"issue":"5","key":"3117_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MCC.0000000000001074","volume":"29","author":"S Dettori","year":"2023","unstructured":"Dettori S, Portunato F, Vena A et al (2023) Severe infections caused by difficult-to-treat Gram-negative bacteria. Curr Opin Crit Care 29(5):438\u2013445. https:\/\/doi.org\/10.1097\/MCC.0000000000001074","journal-title":"Curr Opin Crit Care"},{"key":"3117_CR4","unstructured":"European Centre for Disease Prevention and Control. ECDC (2019) https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-systems-overview-2019. Accessed April 2024"},{"key":"3117_CR5","unstructured":"European Centre for Disease Prevention and Control. ECDC (2023) https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx. Accessed December 2023"},{"key":"3117_CR6","doi-asserted-by":"publisher","unstructured":"Ferrara F, Zovi A, Nava E et al (2023) SARS-CoV-2 caused a surge in antibiotic consumption causing a silent pandemic inside the pandemic. A retrospective analysis of Italian data in the first half of 2022. Ann Pharm Fr 28:S0003-4509(23)00022-6. https:\/\/doi.org\/10.1016\/j.pharma.2023.02.003","DOI":"10.1016\/j.pharma.2023.02.003"},{"key":"3117_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.afnr.2018.04.004","volume":"86","author":"D Florez-Cuadrado","year":"2018","unstructured":"Florez-Cuadrado D, Moreno MA, Ugarte-Ru\u00edz M et al (2018) Antimicrobial resistance in the food chain in the European Union. Adv Food Nutr Res 86:115\u2013136","journal-title":"Adv Food Nutr Res"},{"key":"3117_CR8","doi-asserted-by":"publisher","unstructured":"Giddins MJ, Macesic N, Annavajhala MK et al (2018) Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates. Antimicrob Agents Chemother 62. https:\/\/doi.org\/10.1128\/AAC.02101-17","DOI":"10.1128\/AAC.02101-17"},{"key":"3117_CR9","unstructured":"Italian Medicines Agency AIFA (2023). https:\/\/www.aifa.gov.it\/documents\/20142\/1787183\/AIFA-OPERA_Raccomandazioni_pazienti_ospedalizzati.pdf. Accessed April 2024"},{"key":"3117_CR10","unstructured":"Italian Medicines Agency AIFA (2024) https:\/\/www.aifa.gov.it\/documents\/20142\/1787183\/AIFAOPERA_Raccomandazioni_pazienti_ospedalizzati.pdf. Accessed January 2024"},{"key":"3117_CR11","unstructured":"Italian Ministry of Health (2022a) https:\/\/www.salute.gov.it\/portale\/antibioticoresistenza\/glossarioAntibioticoResistenza.jsp?lingua=italiano&area=antibiotico-resistenza&menu=glossario&tab=1. Accessed January 2024"},{"key":"3117_CR12","unstructured":"Italian Ministry of Health (2022b) Piano Nazionale di Contrasto all\u2019Antibiotico-Resistenza (PNCAR) 2022\u20132025. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3294_allegato.pdf. Accessed December 2023"},{"key":"3117_CR13","unstructured":"Italian Superior Institute of Health (2019) https:\/\/www.iss.it\/one-health. Accessed December 2023"},{"issue":"1","key":"3117_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-019-0662-8","volume":"9","author":"A Lepape","year":"2020","unstructured":"Lepape A, Jean A, De Waele J et al (2020) European intensive care physicians\u2019 experience of infections due to antibiotic-resistant bacteria. Antimicrob Resist Infect Control 9(1):1","journal-title":"Antimicrob Resist Infect Control"},{"issue":"13","key":"3117_CR15","doi-asserted-by":"publisher","first-page":"1157010","DOI":"10.3389\/fcimb.2023.1157010","volume":"20","author":"D Li","year":"2023","unstructured":"Li D, Huang X, Rao H et al (2023) Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol 20(13):1157010. https:\/\/doi.org\/10.3389\/fcimb.2023.1157010","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"3117_CR16","first-page":"209","volume":"8","author":"J Littmann","year":"2015","unstructured":"Littmann J, Viens AM (2015) The ethical significance of antimicrobial resistance. Public Health Ethics 8(3):209\u2013224","journal-title":"Public Health Ethics"},{"key":"3117_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/mdr.2017.0061","volume":"24","author":"P Liu","year":"2018","unstructured":"Liu P, Li X, Luo M et al (2018) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist 24:190\u2013198","journal-title":"Microb Drug Resist"},{"key":"3117_CR18","doi-asserted-by":"publisher","unstructured":"McEwen SA, Collignon PJ (2018) Antimicrobial resistance: a one health perspective. Microbiol Spectr 6(2). https:\/\/doi.org\/10.1128\/microbiolspec.ARBA-0009-2017","DOI":"10.1128\/microbiolspec.ARBA-0009-2017"},{"key":"3117_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P et al (2022) European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin Microbiol Infect 28:521\u2013547","journal-title":"Clin Microbiol Infect"},{"key":"3117_CR20","volume":"57","author":"S P\u00e9rez-Galera","year":"2023","unstructured":"P\u00e9rez-Galera S, Bravo-Ferrer JM, Paniagua M et al (2023) Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA). E Clin Med 57:101871","journal-title":"E Clin Med"},{"key":"3117_CR21","unstructured":"Quotidiano Sanit\u00e0 (2024) Antibiotico resistenza. Via libera dell\u2019Aifa alla nuova terapia per contrastarla e razionalizzare l\u2019uso di carbapenemici. https:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=44968. Accesed January 2024"},{"issue":"10","key":"3117_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/civ097","volume":"60","author":"J Solomkin","year":"2015","unstructured":"Solomkin J, Hershberger E, Miller B et al (2015) Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis 60(10):1462\u201371. https:\/\/doi.org\/10.1093\/cid\/civ097","journal-title":"Clin Infect Dis"},{"key":"3117_CR23","unstructured":"WHO (2015) Global action plan on antimicrobial resistance.  https:\/\/www.who.int\/publications\/i\/item\/9789241509763. Accessed Jan 2024."},{"issue":"4","key":"3117_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","volume":"56","author":"M Zeng","year":"2023","unstructured":"Zeng M, Xia J, Zong Z et al (2023) Society of Bacterial Infection and Resistance of Chinese Medical Association; Expert Committee on Clinical Use of Antimicrobial Agents and Evaluation of Antimicrobial Resistance of the National Health Commission; Infectious Diseases Society of Chinese Medical Education Association. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56(4):653\u2013671. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.017","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03117-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03117-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03117-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:08:48Z","timestamp":1727960928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03117-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3117"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03117-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors consent to the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the opinions expressed are of a personal nature and do not in any way commit the responsibility of the administrations to which they belong.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}